Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis

Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis

Introduction and Objectives: Microbial translocation contributes to cirrhosis progression and complications. This study aims to investigate whether molecules related to intestinal permeability or microbial translocation can serve as prognostic biomarkers in patients with decompensated cirrhosis. Mat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, Flavia Ferreira Fernandes, Renata de Mello Perez, Heitor Siffert Pereira de Souza
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Annals of Hepatology
Subjects:	Cirrhosis Microbial translocation Zonulin Calprotectin Beta-glucan
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268124003508
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of fecal zonulin and calprotectin levels with cardiovascular risk factors and target organ damage in a sample of patients with metabolic disorders
by: E. P. Kolesova, et al.
Published: (2023-11-01)

Biological markers of disease activity in inflammatory bowel diseases
by: Edyta Szymanska, et al.
Published: (2023-07-01)

Cytokine and Antimicrobial Peptide Levels in Cholelithiasis
by: K. F. Gasimova
Published: (2021-03-01)

Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
by: Anja Tiede, et al.
Published: (2025-01-01)

COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01)

Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis
by: Ping Qi, et al.
Published: (2025-06-01)

PERFORMANCE OF SIX PREDICTIVE MODELS OF DEATH OF PATIENTS HOSPITALIZED FOR DECOMPENSATED CIRRHOSIS: A MULTICENTER STUDY
by: Ajácio Bandeira de Mello BRANDÃO, et al.
Published: (2025-04-01)

Correction of renal dysfunction in patients with the decompensated course of cirrhosis
by: A. S. Tugushev, et al.
Published: (2014-06-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Recompensation in patients with autoimmune hepatitis-related decompensated cirrhosis following immunosuppressive therapy
by: Yu Chen, et al.
Published: (2025-09-01)

Microbiota and intestinal permeability as drivers of gastroenterological manifestations of new coronavirus infection (COVID-19)
by: K. V. Kozlov, et al.
Published: (2021-12-01)

Modern concept of bacterial complications at liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2010-12-01)

Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis
by: K. S. Zemlyanukhina, et al.
Published: (2024-10-01)

Alterations in neutrophil extracellular traps is associated with the degree of decompensation of liver cirrhosis
by: Juan M Agraz-Cibrian, et al.
Published: (2016-05-01)

Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty
by: Raquel Díaz-Ruíz, et al.
Published: (2025-03-01)

Predictive Factors and Nomogram for Spontaneous Bacterial Peritonitis in Decompensated Cirrhosis Among the Elderly
by: Yan F, et al.
Published: (2024-12-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

Factors associated with early hospital readmission for acute decompensation of cirrhosis - prospective cohort study
by: Tamara Liana Zocche, et al.
Published: (2025-02-01)

IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE
by: Leticia Macedo EIFLER, et al.
Published: (2024-11-01)

Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
by: Qiaofeng Chen, et al.
Published: (2025-03-01)

Prevalence of the most common external manifestations and comorbidities in men with decompensated alcoholic liver cirrhosis
by: Bokan Goran, et al.
Published: (2025-01-01)

Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model
by: Xiaolong Zheng, et al.
Published: (2025-05-01)

Serum Zonulin and Its Role in Rosacea Pathogenesis: A Comprehensive Estimation Study
by: Fatma Shabaka, et al.
Published: (2025-07-01)

Two poles of the anti-inflammatory action of azithromycin
by: E. N. Lazareva, et al.
Published: (2023-07-01)

Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study
by: Prerna Sharma, et al.
Published: (2025-03-01)

Bacterial infection adversely increases the risk of decompensation in patients with hepatitis B virus-related compensated cirrhosis: a retrospective study
by: Yinglun Li, et al.
Published: (2024-12-01)

Changes in the Structural and Functional Albumin Properties in Patients with Decompensated Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2023-06-01)

Assessment of hemodynamic parameters of hepatic and visceral blood flow in decompensated liver cirrhosis
by: A. S. Tugushev, et al.
Published: (2021-06-01)

Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver Cirrhosis
by: Valeriy D. Lunkov, et al.
Published: (2019-03-01)

Neutrophil-derived ratios as predictors of short-term mortality in HBV-associated decompensated cirrhosis
by: Yang Xiang, et al.
Published: (2025-05-01)

Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome
by: Balasubramaniyan Vairappan, et al.
Published: (2025-05-01)

Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis
by: Lu Chen, et al.
Published: (2025-08-01)

Hyponatraemia Induced by Terlipressin in Patients Diagnosed with Decompensated Liver Cirrhosis and Acute Variceal Bleeding
by: Mahmoud Elshehawy, et al.
Published: (2025-03-01)

Extirpation of rectum for cancer in patient with decompensated liver cirrhosis and portal hypertension
by: P. V. Tsarkov, et al.
Published: (2011-09-01)

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
by: Chuan Liu, et al.
Published: (2025-01-01)

From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
by: Akhil Deshmukh, et al.
Published: (2025-04-01)

Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK [version 1; peer review: 2 approved]
by: Yvanne Enever, et al.
Published: (2024-11-01)

Serum zonulin level in autistic children and its relation to severity of symptoms a case-control study
by: Hassan Mohammed Sonbol, et al.
Published: (2025-07-01)

Relationship of serum hepatitis B Virus DNA levels with Hepcidin, Pentraxin-3, Zonulin, and Copeptin in chronic hepatitis B patients
by: Burak Ezer, et al.
Published: (2025-04-01)